Skip to main content
Premium Trial:

Request an Annual Quote

USAID, Broad, Illumina Partner to Help with Ebola Genome Surveillance in West Africa

NEW YORK (GenomeWeb) – The US Agency for International Development (USAID), the Broad Institute of MIT and Harvard, and Illumina have partnered to help with Ebola genome surveillance in several West African countries that have been affected by the epidemic.

As part of their partnership, they will equip facilities in West Africa with genome sequencing technology, train personnel to sequence viral genomes from outbreaks, and extend Ebola surveillance operations.

Sequencing and patient monitoring facilities will be created first in Liberia, Nigeria, Senegal, and Sierra Leone, and longer term in other West African countries. These centers will also deploy mobile laboratories to remote areas.

Researchers led by Pardis Sabeti at the Broad Institute have already been collaborating with groups in Nigeria, Senegal, and Sierra Leone for several years, training them to use sequencing and diagnostic technology, and they plan to extend their work to Liberia.

"The generosity of our partners will enable our outstanding African collaborators to provide real-time information about the circulation and mutation of Ebola virus strains, which is critical for keeping diagnostics, vaccines, and therapies up to date," Sabeti, an associate professor at Harvard University and a senior associate member of the Broad, said in a statement. "And, importantly, this partnership will build long-term strength in Africa for genomic surveillance."

Illumina will provide its MiSeq sequencing platform to several African laboratories, starting with the groups of Christian Happi at Redeemer's University in Nigeria and Daouda Ndiaye at Université Cheikh Anta Diop in Senegal. Labs in Liberia and Sierra Leone will also receive MiSeq instruments. Happi's group plans to use the equipment to sequence samples from the 20 confirmed and suspected Ebola cases from the Nigerian outbreak that ended in October.

Eleven researchers from Nigeria and Senegal have already completed training in genomics at the Broad Institute this summer, with support from the National Institutes of Health and the World Bank.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.